ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA
Clinical trial NCT01730612 · COMPLETED
Trial details
- NCT number
- NCT01730612
- Sponsor
- Nantes University Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2017-05-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.